Which category benefits most from raw sourcing — GH peptides or AAS injectables?

Peptides are more sensitive to degradation than AAS

Raw sourcing impacts GH effectiveness more noticeably

Peptide dosing accuracy matters more for results.

Poor peptide quality little to no effect.

AAS usually work even at slightly lower purity.

GH peptides rely heavily on proper synthesis quality

Raw peptides can drastically outperform underdosed finished vials

Injectables are easier to verify via bloodwork.

Peptides suffer more from storage and handling issues.

GH peptides show bigger consistency gains when sourced well.